Position in BSX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$554,840
-$2,236,593 QoQ
Shares Held
13,000
-70.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#822
of 1,468 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Derivatives in BSX
reported options exposure · as of Jun 30, 2026CallValue
$426,800
CallShares
10,000
PutValue
$1,067,000
PutShares
25,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026J. Goldman & Co LP holds $6,892,157 across 3 Medical Devices names. BSX ranks #2 (8.1% of the industry book) .
All Filings in BSX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,067,000 | 25,000 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $554,840 | 13,000 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $426,800 | 10,000 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $2,666,875 | 42,500 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $2,791,433 | 44,485 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $8,314,375 | 132,500 | Call | Sole | 2026-05-15 | |
| 2024-03-31 | $1,536,915 | 22,440 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,058,375 | 87,500 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $1,735,051 | 30,013 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $819,878 | 15,528 | Shares | Sole | 2023-11-14 | |
| 2020-03-31 | $3,508,181 | 107,514 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||